A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic Participants
Clinical trial NCT06947408 · COMPLETED
Trial details
- NCT number
- NCT06947408
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-14
- Primary completion
- 2026-05-11
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.